Chronic Familial NeutropeniaSymptoms, Doctors, Treatments, Advances & More
Chronic Familial Neutropenia Overview
Learn About Chronic Familial Neutropenia
Sassan Farjami is a Hematologist and an Oncologist practicing medicine in Long Beach, California. Dr. Farjami is rated as an Advanced provider by MediFind in the treatment of Chronic Familial Neutropenia. He is also highly rated in 53 other conditions, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Colorectal Cancer, Paget Disease of the Breast, Lynch Syndrome, and Gastrostomy. Dr. Farjami is board certified in Internal Medicine (Sub: Medical Oncology), Internal Medicine (Sub: Hematology), American Board Internal Medicine, Internal Medicine, and Internal Medicine (Sub: Geriatric Medicine). Dr. Farjami is currently accepting new patients.
Suburban Hematology Oncology Associates
Debra Miller is an Oncologist practicing medicine in Snellville, Georgia. Dr. Miller is rated as an Advanced provider by MediFind in the treatment of Chronic Familial Neutropenia. She is also highly rated in 25 other conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Lung Cancer, and Pleuropulmonary Blastoma. Dr. Miller is board certified in American Board Of Internal Medicine - Medical Oncology. Dr. Miller is currently accepting new patients.
McGlinn Cancer Institute - Reading Hospital, Phoenixville Campus
Le Wang is a Hematologist and an Oncologist practicing medicine in Phoenixville, Pennsylvania. Dr. Wang is rated as an Advanced provider by MediFind in the treatment of Chronic Familial Neutropenia. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Anemia, Idiopathic Neutropenia, Agranulocytosis, and Thrombocytopenia. Dr. Wang is board certified in American Board Of Internal Medicine. Dr. Wang is currently accepting new patients.
Summary: The purpose of this study is to demonstrate the efficacy and evaluate the safety and tolerability of mavorixafor in participants with congenital or acquired primary autoimmune and idiopathic chronic neutropenic disorders who are experiencing recurrent and/or serious infections as assessed by demonstrating its clinical benefit and increasing levels of circulating neutrophils.
Summary: The goal of this observational study is to characterize the diagnostic and therapeutic management of autoimmune cytopenias including autoimmune hemolytic anemia, immune thrombocytopenia, and chronic idiopathic/autoimmune neutropenia. The main aims to answer are: * evaluation of traditional and novel diagnostic tools including immunohematology, cytokine essays, bone marrow studies, molecular findin...


